Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells
Open Access
- 1 November 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 297 (5) , C1062-C1070
Abstract
Angiotensin II (ANG II) is a major regulator of blood pressure that essentially acts through activation of ANG II type 1 receptor (AT1R) of vascular smooth muscle cells (VSMC). AT1R activates numerous intracellular signaling pathways, including the small G protein RhoA known to control several VSMC functions. Nevertheless, the mechanisms leading to RhoA activation by AT1R are unknown. RhoA activation can result from activation of RhoA exchange factor and/or inhibition of Rho GTPase-activating protein (GAP). Here we hypothesize that a RhoGAP could participate to RhoA activation induced by ANG II in rat aortic VSMC. The knockdown of the RhoGAP p190A by small interfering RNA (siRNA) abolishes the activation of RhoA-Rho kinase pathway induced after 5 min of ANG II (0.1 μM) stimulation in rat aortic VSMC. We then show that AT1R activation induces p190A dephosphorylation and inactivation. In addition, expression of catalytically inactive or phosphoresistant p190A mutants increases the basal activity of RhoA-Rho kinase pathway, whereas phosphomimetic mutant inhibits early RhoA activation by ANG II. Using siRNA and mutant overexpression, we then demonstrate that the tyrosine phosphatase SHP2 is necessary for 1) maintaining p190A basally phosphorylated and activated by the tyrosine kinase c-Abl, and 2) inducing p190A dephosphorylation and RhoA activation in response to AT1R activation. Our work then defines p190A as a new mediator of RhoA activation by ANG II in VSMC.Keywords
This publication has 48 references indexed in Scilit:
- p190RhoGAP negatively regulates Rho activity at the cleavage furrow of mitotic cellsExperimental Cell Research, 2009
- Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHRCirculation Research, 2008
- Central Role of Gqin the Hypertrophic Signal Transduction of Angiotensin II in Vascular Smooth Muscle CellsEndocrinology, 2008
- Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I–Converting Enzyme LevelsHypertension, 2007
- Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive ratsJournal Of Hypertension, 2007
- Integrin Signaling through Arg Activates p190RhoGAP by Promoting Its Binding to p120RasGAP and Recruitment to the MembraneMolecular Biology of the Cell, 2006
- Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II‐induced activation of the SHP‐2 tyrosine phosphataseJournal of Cellular Physiology, 2005
- GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factorsNature Reviews Molecular Cell Biology, 2005
- Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migrationJournal of Cell Biology, 2002
- p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculationNature Cell Biology, 2001